Fidelity Investments
STRO icon

Fidelity Investments’s Sutro Biopharma STRO Stock Holding History

Fidelity Investments’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.2K Sell
1,050
-58
-5% -$1.05K ﹤0.01% 4410
2025
Q4 		$12.8K Sell
1,108
-78
-7% -$740 ﹤0.01% 4646
2025
Q3 		$10.3K Buy
1,186
+22
+2% +$187 ﹤0.01% 4601
2025
Q2 		$8.31K Sell
1,164
-4,991
-81% -$40.8K ﹤0.01% 4580
2025
Q1 		$40K Sell
6,155
-21,634
-78% -$341K ﹤0.01% 3948
2024
Q4 		$511K Buy
27,789
+8,885
+47% +$271K ﹤0.01% 2918
2024
Q3 		$654K Buy
18,904
+3,770
+25% +$148K ﹤0.01% 2750
2024
Q2 		$443K Buy
15,134
+3,902
+35% +$154K ﹤0.01% 2774
2024
Q1 		$635K Buy
11,232
+2,673
+31% +$118K ﹤0.01% 2645
2023
Q4 		$367K Buy
8,559
+533
+7% +$16.9K ﹤0.01% 2771
2023
Q3 		$279K Buy
8,026
+75
+0.9% +$3.27K ﹤0.01% 2779
2023
Q2 		$370K Sell
7,951
-406
-5% -$20.2K ﹤0.01% 2755
2023
Q1 		$386K Sell
8,357
-54,076
-87% -$3.43M ﹤0.01% 2773
2022
Q4 		$5.04M Sell
62,433
-12,213
-16% -$849K ﹤0.01% 2117
2022
Q3 		$4.14M Buy
74,646
+8,205
+12% +$486K ﹤0.01% 2228
2022
Q2 		$3.46M Sell
66,441
-7,327
-10% -$409K ﹤0.01% 2338
2022
Q1 		$6.06M Buy
73,768
+38
+0.1% +$3.62K ﹤0.01% 2309
2021
Q4 		$11M Hold
73,730
– – ﹤0.01% 2081
2021
Q3 		$13.9M Hold
73,730
– – ﹤0.01% 1985
2021
Q2 		$13.7M Hold
73,730
– – ﹤0.01% 1990
2021
Q1 		$16.8M Buy
73,730
+19,430
+36% +$4.61M ﹤0.01% 1855
2020
Q4 		$11.8M Buy
54,300
+20,440
+60% +$3.38M ﹤0.01% 1912
2020
Q3 		$3.4M Buy
33,860
+24,210
+251% +$2.29M ﹤0.01% 2173
2020
Q2 		$749K Buy
9,650
+10
+0.1% +$960 ﹤0.01% 2447
2020
Q1 		$983K Sell
9,640
-6,230
-39% -$655K ﹤0.01% 2333
2019
Q4 		$1.75M Sell
15,870
-6,390
-29% -$659K ﹤0.01% 2286
2019
Q3 		$2.02M Sell
22,260
-5,497
-20% -$555K ﹤0.01% 2273
2019
Q2 		$3.16M Sell
27,757
-12,243
-31% -$1.35M ﹤0.01% 2218
2019
Q1 		$4.56M Sell
40,000
-35
-0.1% -$3.64K ﹤0.01% 2104
2018
Q4 		$3.61M Buy
40,035
+35
+0.1% +$4.22K ﹤0.01% 2135
2018
Q3 		$6M Buy
+40,000
New +$6.04M ﹤0.01% 2093

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Fidelity Investments's STRO Position: Q1 2026 in Review

Fidelity Investments reduced its Sutro Biopharma (STRO) stake by 5.2% in Q1 2026, selling an estimated $1.05K and leaving 1,050 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4410.

Fidelity Investments first reported a position in STRO in Q3 2018 and has held it in 31 quarters since. The position peaked at $16.8M in Q1 2021. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Fidelity Investments held 1,050 shares of Sutro Biopharma worth $26.2K as of Q1 2026.
  • Fidelity Investments sold 58 Sutro Biopharma shares in Q1 2026, an estimated $1.05K.
  • Sutro Biopharma made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4410 holding.
  • Fidelity Investments first reported a position in Sutro Biopharma in Q3 2018 and has held it in 31 quarters since.
  • Fidelity Investments's Sutro Biopharma position peaked at $16.8M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.